byiShook Opinion
Sep 20, 2024 - 11:30
Novo Nordisk stock tumbled Friday — pulling Corbus into a steep dive — after its new obesity drug caused neuropsychiatric side effects. The post Novo Dives — And Corbus Crashes — After New Weight-Loss Drug Causes Neuropsychiatric Effects appeared first on Investor's Business Daily.
Novo Nordisk stock tumbled Friday â pulling Corbus into a steep dive â after its new obesity drug caused neuropsychiatric side effects.
The post Novo Dives â And Corbus Crashes â After New Weight-Loss Drug Causes Neuropsychiatric Effects appeared first on Investor's Business Daily.